TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,717 Cr | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr | ₹4,892 Cr |
What is the latest Total Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹4,717 Cr |
| Mar2024 | ₹5,425 Cr |
| Mar2023 | ₹5,447 Cr |
| Mar2022 | ₹4,415 Cr |
| Mar2021 | ₹4,892 Cr |
How is Total Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,717 Cr | -13.05 | |
| Mar2024 | ₹5,425 Cr | -0.40 | |
| Mar2023 | ₹5,447 Cr | 23.38 | |
| Mar2022 | ₹4,415 Cr | -9.74 | |
| Mar2021 | ₹4,892 Cr | - | |
Compare Total Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹135,211.1 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,977.0 Cr | -0.4% | -10.9% | -16.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.3% |
-3.7% |
24% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses